William Mack & Associates
ALAB icon

William Mack & Associates’s Astera Labs ALAB Stock Holding History

William Mack & Associates’s Portfolio ALAB Stock Details ALAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.42K Buy
+4
New +$1.29K ﹤0.01% 635

Other funds holding ALAB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $165B AUM 72.14% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

William Mack & Associates's ALAB Position: Q3 2026 in Review

William Mack & Associates opened a new position in Astera Labs (ALAB) in Q3 2026: 4 shares worth $1.42K. The stake represents ﹤0.01% of the portfolio and ranks #635 among its holdings.

804 funds tracked by Wall St. Rank hold ALAB as of Q3 2026.

  • William Mack & Associates held 4 shares of Astera Labs worth $1.42K as of Q3 2026.
  • Astera Labs was a new William Mack & Associates position in Q3 2026.
  • Astera Labs made up ﹤0.01% of William Mack & Associates's portfolio in Q3 2026, its #635 holding.
  • 804 funds tracked by Wall St. Rank held Astera Labs as of Q3 2026.

Based on William Mack & Associates's 13F filing for Q3 2026, filed 27 Oct 2026.